|
Accueil > Actualité
Regeneron: Q2 net income up a quarter
(CercleFinance.com) - Regeneron Pharmaceuticals has reported Q2 2020 adjusted net income that is up 24% at 854 million dollars, or 7.
16 dollars per share, with its revenues also rising by 24% to 1.95 billion dollars. "We are continuing to drive strong performance with our marketed medicines, including EYLEA, Dupixent, and Libtayo," said CEO Leonard Schleifer, who also highlighted the progress of the REGN-COV2 product project against Covid-19. Copyright (c) 2020 CercleFinance.com. All rights reserved. |
19/04/2024 18:06
Alstoma conclu un accord avec Knorr-Bremse 19/04/2024 17:30 Danoneen hausse après deux analyses positives 19/04/2024 16:35 TotalEnergiespartenariat avec OK Petroleum aux USA 19/04/2024 16:29 BAE Systemsmodernise une usine de munitions 19/04/2024 16:15 Netflixle titre trébuche après une publication contrastée 19/04/2024 16:09 Bayersigne un contrat de fourniture d'énergie renouvelables Tous les articles sociétés |
